May 1, 2001 — SAN DIEGO, CA — Fast rising Biotech firm FeRx Inc. has moved into the new 160-acre Colorado Bioscience Park in Aurora.
The San Diego-based company, which recently attracted attention when it developed a method to get more cancer-killing drugs to remain in tumors rather than spread to other areas of the body, will use the Colorado facility for research and development. Officials say the 25 or so scientists and other employees have been reinstalling equipment and certifying the site’s cleanrooms.
Te Bioscience Park, located just outside of Denver, was formerly the Fitzsimmons Army Medical Center. It represents the largest medical-related redevelopment project in the nation.
“Moving our research and operations facility to the Colorado Bioscience Park will allow us opportunities for collaboration and resource sharing with other bioscience companies as well as access to the resources of the University of Colorado Health Sciences Center, the largest academic medical center in the Rocky Mountain Region.”
FeRx is currently completing a Phase I/II clinical trial of its lead compound, MTC-Doxorubicin, in patients with primary liver cancer and recently initiated a Phase I/II study of MTC-DOX in patients with metastatic liver cancer.